Literature DB >> 10837047

The real and the nominal? Making inflationary adjustments to cost and other economic data.

L Kumaranayake1.   

Abstract

Given the scarcity of cost data for health interventions, there has been substantial use of a relatively small number of existing studies to underpin policy development formulation. Intervention-specific cost and cost-effectiveness data have been used to plan overall budgets, to assess the relative efficiency of different interventions and to consider the resource requirements for programme implementation at both the local and national levels. Cost and cost-effectiveness comparisons have been made between these studies and general sources such as the World Bank's World Development Report 1993. At the same time, information on key health sector variables, such as annual health expenditures, has been systematically compiled for more than two decades. The question of possible inflationary effects is becoming increasingly important as the original data on which these numbers are based ages. For example, cost figures from the mid-1980s require a 60% inflationary adjustment simply to maintain their real value in current dollars. This paper looks at methods to adjust cost data to account for inflation and discusses the difference between real or constant and nominal or current values. These methods are also used to make inflationary adjustments to other types of economic data such as income.

Mesh:

Year:  2000        PMID: 10837047     DOI: 10.1093/heapol/15.2.230

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  36 in total

1.  Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

Authors:  Lara J Wolfson; François Gasse; Shook-Pui Lee-Martin; Patrick Lydon; Ahmed Magan; Abdelmajid Tibouti; Benjamin Johns; Raymond Hutubessy; Peter Salama; Jean-Marie Okwo-Bele
Journal:  Bull World Health Organ       Date:  2008-01       Impact factor: 9.408

2.  Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers.

Authors:  P Vickerman; C Watts; R W Peeling; D Mabey; M Alary
Journal:  Sex Transm Infect       Date:  2006-10       Impact factor: 3.519

Review 3.  Costs and cost-effectiveness of malaria control interventions--a systematic review.

Authors:  Michael T White; Lesong Conteh; Richard Cibulskis; Azra C Ghani
Journal:  Malar J       Date:  2011-11-03       Impact factor: 2.979

4.  Cost-effectiveness of helicopter versus ground emergency medical services for trauma scene transport in the United States.

Authors:  M Kit Delgado; Kristan L Staudenmayer; N Ewen Wang; David A Spain; Sharada Weir; Douglas K Owens; Jeremy D Goldhaber-Fiebert
Journal:  Ann Emerg Med       Date:  2013-04-09       Impact factor: 5.721

5.  Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: the case of Kasese district in Uganda.

Authors:  Cristina Carias; Maroya Spalding Walters; Edward Wefula; Kashmira A Date; David L Swerdlow; Maya Vijayaraghavan; Eric Mintz
Journal:  Vaccine       Date:  2015-02-21       Impact factor: 3.641

6.  Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study.

Authors:  Katharina Kranzer; Stephen D Lawn; Gesine Meyer-Rath; Anna Vassall; Eudoxia Raditlhalo; Darshini Govindasamy; Nienke van Schaik; Robin Wood; Linda-Gail Bekker
Journal:  PLoS Med       Date:  2012-08-07       Impact factor: 11.069

7.  Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.

Authors:  Philip Ayieko; Ulla K Griffiths; Moses Ndiritu; Jennifer Moisi; Isaac K Mugoya; Tatu Kamau; Mike English; J Anthony G Scott
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

8.  Predicting treatment cost for bacterial diarrhoea at a regional hospital in Thailand.

Authors:  Arthorn Riewpaiboon; Kwanduen Intraprakan; Sukit Phoungkatesunthorn
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

9.  Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?

Authors:  Richard G White; Kate K Orroth; Judith R Glynn; Esther E Freeman; Roel Bakker; J Dik F Habbema; Fern Terris-Prestholt; Lilani Kumaranayake; Anne Buvé; Richard J Hayes
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

Review 10.  The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.

Authors:  Gabriela B Gomez; Annick Borquez; Kelsey K Case; Ana Wheelock; Anna Vassall; Catherine Hankins
Journal:  PLoS Med       Date:  2013-03-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.